Royalty Pharma (RPRX) News Today $33.09 -1.16 (-3.39%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RPRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Raiffeisen Bank International AG Acquires New Holdings in Royalty Pharma plc (NASDAQ:RPRX)Raiffeisen Bank International AG acquired a new stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 20,000 shares of the biopharmaceutical company's stock, valued at approxMay 20 at 5:38 AM | marketbeat.comBrokerages Set Royalty Pharma plc (NASDAQ:RPRX) Target Price at $42.50May 20 at 1:39 AM | americanbankingnews.comMan Group plc Has $20.80 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Man Group plc lifted its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 113.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 815,427 shares of the biopharmaceutical company's stockMay 19 at 5:18 AM | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Given Consensus Rating of "Buy" by BrokeragesRoyalty Pharma plc (NASDAQ:RPRX - Get Free Report) has received an average rating of "Buy" from the five research firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation, three have assigned a buy recommendation anMay 19 at 4:19 AM | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Earns Overweight Rating from Analysts at Morgan StanleyMay 19 at 2:31 AM | americanbankingnews.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Sold by OMERS ADMINISTRATION CorpOMERS ADMINISTRATION Corp decreased its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 29.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 57,208 shares of the biopharmaceutical compaMay 18 at 4:57 AM | marketbeat.comEthic Inc. Buys 11,597 Shares of Royalty Pharma plc (NASDAQ:RPRX)Ethic Inc. boosted its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 132.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,342 shares of the biopharmaceutical company's stock after purchasMay 18 at 4:17 AM | marketbeat.comMorgan Stanley reinstates Royalty Pharma with Overweight ratingMay 18 at 2:11 AM | uk.investing.comOccudo Quantitative Strategies LP Increases Holdings in Royalty Pharma plc (NASDAQ:RPRX)Occudo Quantitative Strategies LP boosted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 96.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,512 shares of the biopharmaceutical compaMay 17, 2025 | marketbeat.comRoyalty Pharma Completes the Acquisition of Its External ManagerMay 16, 2025 | globenewswire.comPatient Capital Management LLC Has $73.34 Million Stake in Royalty Pharma plc (NASDAQ:RPRX)Patient Capital Management LLC increased its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 40.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,875,0May 16, 2025 | marketbeat.comBalyasny Asset Management L.P. Purchases Shares of 59,755 Royalty Pharma plc (NASDAQ:RPRX)Balyasny Asset Management L.P. purchased a new stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 59,755 shares of the biopharmaceutical company'May 16, 2025 | marketbeat.comBaird Financial Group Inc. Takes $1.59 Million Position in Royalty Pharma plc (NASDAQ:RPRX)Baird Financial Group Inc. bought a new stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 62,191 shares of the biopharmaceutical company's stock, valuedMay 15, 2025 | marketbeat.comBank of America Corp DE Purchases 950,880 Shares of Royalty Pharma plc (NASDAQ:RPRX)Bank of America Corp DE grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 46.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,985,585 shares of the biopharmacMay 15, 2025 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Upgraded by StockNews.com to Buy RatingStockNews.com raised shares of Royalty Pharma from a "hold" rating to a "buy" rating in a research note on Monday.May 15, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Position Raised by Deutsche Bank AGDeutsche Bank AG lifted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 36.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,189,964 shares of the biopharmaceutical company's stock after acquiring an additional 847,704 shares dMay 14, 2025 | marketbeat.comRoyalty Pharma to Present at Upcoming Investor ConferencesMay 13, 2025 | globenewswire.comD. E. Shaw & Co. Inc. Raises Holdings in Royalty Pharma plc (NASDAQ:RPRX)D. E. Shaw & Co. Inc. lifted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 24.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,161,304 shares of the biopharmaceutical company's stock after purcMay 13, 2025 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Upgraded to "Buy" at StockNews.comMay 13, 2025 | americanbankingnews.comRoyalty Pharma Announces Shareholder Approval of its External Manager AcquisitionMay 12, 2025 | globenewswire.comRoyalty Pharma: Again, Guidance Raised, Buy ConfirmedMay 11, 2025 | seekingalpha.comRoyalty Pharma plc (NASDAQ:RPRX) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comCrestline Management LP Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Crestline Management LP boosted its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 360.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 101,578 shares of the biopharmaceutical company's stock after buying an additional 79,May 10, 2025 | marketbeat.comBridgefront Capital LLC Acquires New Shares in Royalty Pharma plc (NASDAQ:RPRX)Bridgefront Capital LLC bought a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 12,205 shares of the biopharmaceutical company's stock, valued at approxMay 10, 2025 | marketbeat.com1,644,804 Shares in Royalty Pharma plc (NASDAQ:RPRX) Purchased by BNP Paribas Financial MarketsBNP Paribas Financial Markets bought a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 1,644,804 shares of the biopharmaceutical company's stock, valued atMay 10, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Stake Raised by Axa S.A.Axa S.A. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 761.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 156,131 shares of the biopharmaceutical company's stMay 10, 2025 | marketbeat.comRoyalty Pharma PLC (RPRX) Q1 2025 Earnings Call Highlights: Strong Growth in Royalty Receipts ...May 9, 2025 | finance.yahoo.comRoyalty Pharma (NASDAQ:RPRX) Posts Q1 Sales In Line With EstimatesMay 9, 2025 | msn.com10,893 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by Corton Capital Inc.Corton Capital Inc. acquired a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 10,893 shares of the biopharmaceutical company's stock, valued at apprMay 9, 2025 | marketbeat.comRoyalty Pharma plc (RPRX) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comRoyalty Pharma plc 2025 Q1 - Results - Earnings Call PresentationMay 8, 2025 | seekingalpha.comCutter Capital Management LP Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Cutter Capital Management LP boosted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 15.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 764,859 shares of the biopharmaceutical companMay 8, 2025 | marketbeat.comRoyalty Pharma Reports First Quarter 2025 ResultsMay 8, 2025 | globenewswire.comSchonfeld Strategic Advisors LLC Raises Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Schonfeld Strategic Advisors LLC grew its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 77.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 79,142 shares of the biopharmaceutical company's stock after acquiring an additional 34,537May 8, 2025 | marketbeat.comRoyalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of EarningsMay 7, 2025 | finance.yahoo.comNorthern Trust Corp Acquires 376,619 Shares of Royalty Pharma plc (NASDAQ:RPRX)Northern Trust Corp grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 12.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,330,429 shares of the biopharmaceutical company's stock after buying an addMay 7, 2025 | marketbeat.comArrowMark Colorado Holdings LLC Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)ArrowMark Colorado Holdings LLC increased its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 442.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 389,448 shares of the biopharmaceutical company's sMay 6, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Lowers Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Price T Rowe Associates Inc. MD cut its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 13.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 246,447 shares of the biopharmaceuticMay 6, 2025 | marketbeat.comDimensional Fund Advisors LP Has $42.87 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Dimensional Fund Advisors LP increased its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 52.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,680,535 shares of the biopharmaceuticaMay 6, 2025 | marketbeat.com387,567 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by AlTi Global Inc.AlTi Global Inc. purchased a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 387,567 shares of the biopharmaceutical company's stock, valued at approximateMay 5, 2025 | marketbeat.comCaisse DE Depot ET Placement DU Quebec Purchases Shares of 712,785 Royalty Pharma plc (NASDAQ:RPRX)Caisse DE Depot ET Placement DU Quebec acquired a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 712,785 shares of the biopharmaceutical company's stock, valued at approximatelMay 5, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Purchased by AQR Capital Management LLCAQR Capital Management LLC boosted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 187.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,903,676 shares of the biopharmaceutical company'May 4, 2025 | marketbeat.comMML Investors Services LLC Acquires Shares of 46,800 Royalty Pharma plc (NASDAQ:RPRX)MML Investors Services LLC bought a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 46,800 shares of the biopharmaceutical company's stock, valued at approximately $1,194,000. Several othMay 4, 2025 | marketbeat.comRoyalty Pharma (RPRX) to Release Earnings on ThursdayRoyalty Pharma (NASDAQ:RPRX) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-royalty-pharma-plc-stock/)May 3, 2025 | marketbeat.comRegal Partners Ltd Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Regal Partners Ltd grew its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 21.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,435,956 shares of the biopharmaceutical company's stock aMay 2, 2025 | marketbeat.comPDT Partners LLC Buys 38,599 Shares of Royalty Pharma plc (NASDAQ:RPRX)PDT Partners LLC lifted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 124.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 69,533 shares of the biopharmaceutical company's stock after buyinMay 2, 2025 | marketbeat.comHsbc Holdings PLC Cuts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Hsbc Holdings PLC lessened its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 15.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 172,316 shares of the biopharmaceutiMay 2, 2025 | marketbeat.comTudor Investment Corp ET AL Has $18.75 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX)Tudor Investment Corp ET AL raised its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 44.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 735,027 shares of the biopharmaceutical cApril 30, 2025 | marketbeat.comFirst Trust Advisors LP Sells 157,472 Shares of Royalty Pharma plc (NASDAQ:RPRX)First Trust Advisors LP lowered its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 16.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 798,508 shares of the biopharmaceutiApril 29, 2025 | marketbeat.comWells Fargo & Company MN Acquires 15,790 Shares of Royalty Pharma plc (NASDAQ:RPRX)Wells Fargo & Company MN boosted its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 29.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 70,120 shares of the biopharmaceutical company'April 28, 2025 | marketbeat.com Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address RPRX Media Mentions By Week RPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPRX News Sentiment▼1.040.97▲Average Finance News Sentiment RPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPRX Articles This Week▼178▲RPRX Articles Average Week Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zoetis News Today Corcept Therapeutics News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPRX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
